Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06196489

Adapting an Intervention for Vaping in Young Veterans

The objective of this proposal is to adapt an evidence-based combustible tobacco counseling intervention following an evidence-based process to include e-cigarette use and update its components for emerging adults (EA).

1. Examine factors related to e-cigarette use, barriers to cessation, and facilitators of use of cessation services among an EA population. 2. Beta-test an initial version of the intervention, delivered via video telehealth and telephone, to examine usability and acceptability.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Veterans Medical Research Foundation

San Diego, California, 92161, United States

Location status: Recruiting

Location contact

Neal Doran

CONTACT

[email protected]

858-552-8585

Neal M Doran, PhD

PRINCIPAL_INVESTIGATOR

About this study

Use of electronic nicotine products (ENDS) has increased dramatically especially among young adults (EA- aged 18-30) and has been found to lead to immediate harmful health effects and increased addiction to combustible cigarette use. To date no research-tested interventions have been developed for helping people stop use of electronic nicotine products. Emerging adulthood is a developmental period that can lead to adoption of health risk behaviors.

This proposal aims to address nicotine addiction by adapting an evidence-based counseling cessation intervention developed by the American Cancer Society (ACS) for a general population of combustible tobacco smokers, but found to be effective in EA. We will test two methods of providing counseling to participants: video telehealth or telephone. Primary outcome: Compared to self-help guide only, at 3 month follow-up, we hypothesize that participants in either counseling arm will have higher rates as compared to self-help only control of 7-day abstinence from using any nicotine product.

This study fills a critical gap in ENDS research and will provide a model for further research into all-nicotine cessation in this vulnerable population.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • daily e-cigarette user for at least the past 6 months
  • 18-30 years old
  • willing to enroll in a program to quit nicotine use within 30 days
  • owns smartphone or computer/tablet with camera and internet connectivity
  • English speaker

Exclusion criteria

  • ICD-10 diagnosis of dementia
  • current use of combustible tobacco products at least weekly

Treatment and study plan

adapted vaping cessation intervention

Behavioral

Behavioral intervention for vaping cessation

Primary outcomes

  1. e-cigarette use frequency

    Time frame: end of treatment (8 weeks post-baseline) and 30 days thereafter

    number of days using e-cigarettes in the past 7 days at the time of assessment

  2. e-cigarette use quantity

    Time frame: end of treatment (8 weeks post-baseline) and 30 days thereafter

    number of e-cigarette uses per day

  3. Client Satisfaction Questionnaire (CSQ-8)

    Time frame: end of treatment (8 weeks post-baseline) and 30 days thereafter

    Participant satisfaction ratings; higher scores indicate greater satisfaction with the intervention

Study contacts

Contact information is provided by the study sponsor or research team.

Neal M Doran, PhD

CONTACT

[email protected]

858-552-8585

Sponsors and collaborators

Lead sponsor

Veterans Medical Research Foundation

Other

Collaborators

  • University of California

Registry information

Official study title

Nicotine Cessation: Adapting a Counseling Program for Emerging Adults

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jan 9, 2024
Registry last updated
Jan 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.